CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2022-06-07 | TZIANABOS ARTHUR Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2022-06-07 | Smith Julie Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2022-06-02 | Tulipano Stephen J CFO | Option exercise | +11,160 | $4.48 | $50K | 11,762 |
| 2022-06-02 | Tulipano Stephen J CFO | Option exercise · Employee Stock Option (Right to Buy) | −11,160 | 168,837 | ||
| 2022-05-25 | Kaye Edward M. MD CEO | Option exercise | +15,000 | $0.60 | $9K | 25,000 |
| 2022-05-25 | Kaye Edward M. MD CEO | Option exercise · Employee Stock Option (right to buy) | −15,000 | 622,801 | ||
| 2022-03-15 | Kaye Edward M. MD CEO | Grant or award · Employee Stock Option (Right to Buy) | +308,000 | 308,000 | ||
| 2022-03-15 | Tulipano Stephen J CFO | Grant or award · Employee Stock Option (Right to Buy) | +107,400 | 107,400 | ||
| 2022-03-15 | Ticho Barry Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +107,400 | 107,400 | ||
| 2022-03-15 | Nash Huw M. COO & CBO | Grant or award · Employee Stock Option (Right to Buy) | +107,400 | 107,400 | ||
| 2022-01-03 | Nash Huw M. COO & CBO | Option exercise | +3,800 | $2.19 | $8K | 3,800 |
| 2022-01-03 | Nash Huw M. COO & CBO | Sale | −1,497 | $22.47 | $34K | 2,303 |
| 2022-01-03 | Nash Huw M. COO & CBO | Sale | −2,103 | $23.40 | $49K | 200 |
| 2022-01-03 | Nash Huw M. COO & CBO | Sale | −200 | $24.07 | $5K | 0 |
| 2022-01-03 | Nash Huw M. COO & CBO | Option exercise · Employee Stock Option (Right to Buy) | −3,800 | 86,822 | ||
| 2021-12-01 | Nash Huw M. COO & CBO | Option exercise | +5,700 | $2.19 | $12K | 5,700 |
| 2021-12-01 | Nash Huw M. COO & CBO | Sale | −3,200 | $23.96 | $77K | 2,500 |
| 2021-12-01 | Nash Huw M. COO & CBO | Sale | −2,500 | $25.06 | $63K | 0 |
| 2021-12-01 | Nash Huw M. COO & CBO | Option exercise · Employee Stock Option (Right to Buy) | −5,700 | 90,622 |
Page 22 of 24 · 461 trades